TuisBV3 • FRA
add
Bavarian Nordic A/S
Vorige sluiting
€26,70
Dagwisseling
€25,66 - €26,70
Jaarwisseling
€19,26 - €42,70
Markkapitalisasie
2,23 mjd USD
Gemiddelde volume
1,27 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
CPH
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (DKK) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,36 mjd | -0,95% |
Bedryfskoste | 486,03 m | -22,90% |
Netto inkomste | 70,49 m | 120,69% |
Netto winsgrens | 5,17 | 120,89% |
Wins per aandeel | 0,90 | -67,86% |
EBITDA | 250,46 m | -34,15% |
Effektiewe belastingkoers | 2,71% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (DKK) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,87 mjd | 24,16% |
Totale bates | 13,95 mjd | 4,10% |
Totale aanspreeklikheid | 3,26 mjd | -19,68% |
Totale ekwiteit | 10,69 mjd | — |
Uitstaande aandele | 78,32 m | — |
Prys om te bespreek | 0,20 | — |
Opbrengs op bates | 1,66% | — |
Opbrengs op kapitaal | 2,19% | — |
Kontantvloei
Netto kontantverandering
| (DKK) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 70,49 m | 120,69% |
Kontant van bedrywe | -71,63 m | -123,41% |
Kontant van beleggings | 150,15 m | 249,75% |
Kontant van finansiering | 109,92 m | 1 051,60% |
Netto kontantverandering | 180,29 m | -10,03% |
Beskikbare kontantvloei | -914,47 m | -666,57% |
Meer oor
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany and San Diego, California, as well as offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors and virus-like particles in its research and development. Wikipedia
HUB
Gestig
01 Jul. 1992
Webwerf
Werknemers
1 609
